C4 Therapeutics Inc
CCCC - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$414.59M
Close$
$-2.99
195.9% downside
Current Fair Value
195.9% downsideOvervalued by 195.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $414.59 Million |
|---|---|
| Enterprise Value | $419.50 Million |
| Earnings per Share | $-1.27 |
| Beta | 3.08 |
| Outstanding Shares | 130,696,742 |
Return
| Return on Equity | -41.02% |
|---|---|
| Return on Assets | -28.22% |
| Return on Invested Capital | -34.13% |
Valuation & Multiples
| P/E Ratio | -3.37 |
|---|---|
| PEG | 36.77 |
| Price to Sales | -3.12 |
| Price to Book Ratio | 3.12 |
| Enterprise Value to Revenue | -34.56 |
| Enterprise Value to EBIT | -3.95 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.34 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.21
Consensus analyst estimateRevenue Estimate
$7.67 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.19
Consensus analyst estimateRevenue Estimate
$8.52 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 12.11% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.15%▼ 93.83% |
|---|---|
| Total Invested | $647,098▼ 99.88% |
| Investors Holding | 9▼ 149.00% |
About C4 Therapeutics Inc
99 employees
C4 Therapeutics is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer and o...